Papers
3
Total Citations
17
H-Index
3
About
Rong Hua is a leading thoracic surgeon and researcher whose work focuses on advancing surgical treatments for esophageal squamous cell carcinoma, particularly through minimally invasive techniques and real-world evidence. His major contributions include pioneering comparative studies of robot-assisted versus thoracolaparoscopic oesophagectomy, demonstrating the safety and efficacy of robotic approaches for patients with locally advanced disease after neoadjuvant chemoradiotherapy. This landmark 2022 study has garnered 8 citations, reflecting its influence on surgical decision-making. Hua also leads comprehensive annual reports from Shanghai Chest Hospital, a high-volume esophageal cancer center, providing critical real-world data on clinical characteristics and survival outcomes. His 2016 and 2017 reports, with 6 and 3 citations respectively, offer invaluable benchmarks for treatment patterns and prognosis in China, where esophageal cancer remains a leading cause of cancer death. Through these efforts, Hua has established himself as a key voice in evidence-based surgical oncology, helping to shape best practices in esophagectomy and improve long-term outcomes for patients with this challenging disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3